Cite
APA Citation
Yamamoto, N., Fujiwara, Y., Kondo, S., Iwasa, S., Yonemori, K., Shimomura, A., Kitano, S., Shimizu, T., Koyama, T., Ebata, T., Sato, N., Nakai, K., Inatani, M., & Tamura, K. (n.d.). 423PPhase I study of IDO1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with atezolizumab in Japanese patients with advanced solid tumors. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095323619.0x000034